Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joost Boeckmans

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|November 28, 2023
Liver stiffness as a cornerstone in heart disease risk assessmentJoost Boeckmans, Laurent Sandrin, Christian Knackstedt, et al.
Communications Medicine|May 1, 2025
The importance of patient engagement in the multimodal treatment of MASLDJoost Boeckmans, Hannes Hagström, Donna R Cryer, et al.
Pharmacology & Therapeutics|February 4, 2023
Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targetsLiu Yang, Yawen Hao, Joost Boeckmans, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 6, 2025
Clinical Utility of Non-Invasive Tests for Liver Fibrosis in People Living With Alpha-1 Antitrypsin DeficiencyJoost Boeckmans, Jörn M Schattenberg, Malin Fromme, et al.
BMJ Public Health|November 20, 2025
Temporal comorbidity patterns preceding MASLD-related major adverse liver outcomes: a nationwide population-based case-control study in SwedenJoost Boeckmans, Linnea Widman, Rickard Strandberg, et al.
Scandinavian Journal of Gastroenterology|August 11, 2025
Administrative coding for alpha-1 antitrypsin deficiency including the pi*ZZ phenotype is accurate in SwedenJoost Boeckmans, Sofia Ullman, Jonas F Ludvigsson, et al.
Diagnostic Microbiology and Infectious Disease|March 10, 2021
Follow-up testing of borderline SARS-CoV-2 patients by rRT-PCR allows early diagnosis of COVID-19Joost Boeckmans, Reinoud Cartuyvels, Petra Hilkens, et al.
European Journal of Internal Medicine|February 14, 2025
Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort studyJoost Boeckmans, Linnea Widman, Ying Shang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2023
PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic reviewJoost Boeckmans, Alexandra Gatzios, Jörn M Schattenberg, et al.
The Lancet Regional Health. Europe|December 17, 2024
Clinical utility of the Fibrosis-4 index for predicting mortality in patients with heart failure with or without metabolic dysfunction-associated steatotic liver disease: a prospective cohort studyJoost Boeckmans, Jürgen H Prochaska, Alexander Gieswinkel, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Liver International : Official Journal of the International Association for the Study of the Liver|November 28, 2023
Liver stiffness as a cornerstone in heart disease risk assessmentJoost Boeckmans, Laurent Sandrin, Christian Knackstedt, et al.
Communications Medicine|May 1, 2025
The importance of patient engagement in the multimodal treatment of MASLDJoost Boeckmans, Hannes Hagström, Donna R Cryer, et al.
Pharmacology & Therapeutics|February 4, 2023
Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targetsLiu Yang, Yawen Hao, Joost Boeckmans, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 6, 2025
Clinical Utility of Non-Invasive Tests for Liver Fibrosis in People Living With Alpha-1 Antitrypsin DeficiencyJoost Boeckmans, Jörn M Schattenberg, Malin Fromme, et al.
BMJ Public Health|November 20, 2025
Temporal comorbidity patterns preceding MASLD-related major adverse liver outcomes: a nationwide population-based case-control study in SwedenJoost Boeckmans, Linnea Widman, Rickard Strandberg, et al.
Scandinavian Journal of Gastroenterology|August 11, 2025
Administrative coding for alpha-1 antitrypsin deficiency including the pi*ZZ phenotype is accurate in SwedenJoost Boeckmans, Sofia Ullman, Jonas F Ludvigsson, et al.
Diagnostic Microbiology and Infectious Disease|March 10, 2021
Follow-up testing of borderline SARS-CoV-2 patients by rRT-PCR allows early diagnosis of COVID-19Joost Boeckmans, Reinoud Cartuyvels, Petra Hilkens, et al.
European Journal of Internal Medicine|February 14, 2025
Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort studyJoost Boeckmans, Linnea Widman, Ying Shang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2023
PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic reviewJoost Boeckmans, Alexandra Gatzios, Jörn M Schattenberg, et al.
The Lancet Regional Health. Europe|December 17, 2024
Clinical utility of the Fibrosis-4 index for predicting mortality in patients with heart failure with or without metabolic dysfunction-associated steatotic liver disease: a prospective cohort studyJoost Boeckmans, Jürgen H Prochaska, Alexander Gieswinkel, et al.
Pageof 4